Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.100851
Revised: January 23, 2025
Accepted: February 18, 2025
Published online: April 27, 2025
Processing time: 91 Days and 23.4 Hours
Colorectal cancer (CRC) is a common malignant tumor in the digestive system, whose main treatment comprises surgical resection, radiotherapy and che
To investigate the logistic regression analysis of bone metastasis after CRC surgery and related influencing factors.
We selected 100 patients who underwent surgery for CRC and were admitted from February 2018 to February 2024, collected the general data of bone metastasis, and collected the pathological characteristics of patients with bone metastasis. Next, we divided them into groups with and without bone metastasis (Bone metastases group, n = 44; no bone metastases group, n = 56), compared the clinical data of the two groups, and analyzed the risk factors of bone metastasis using logistic regression analysis.
Among the 100 patients, the mean age was 54.33 ± 8.45 years, and most were male (54.55%). The proportion of patients with lytic bone changes was 43.18%. The most common location of combined bone metastasis was the pelvis, whereas only 5 patients had limb transfer. There was a higher incidence of lung than of pancreatic or liver metastases. Regression analysis showed that the primary location of the cancer was rectal cancer. Lymph node involvement, lung metastasis, and no postoperative chemotherapy were the risk factors for postoperative bone metastasis in patients who underwent surgery for CRC
Rectal cancer, lymph node involvement, complicated pulmonary metastasis, and no postoperative chemotherapy treatment can help predict high risk of bone metastasis in CRC.
Core Tip: Early identification of bone metastasis risk in colorectal cancer patients is critical, especially pre- and post-surgery. Targeted interventions for risk factors are essential. These may include bone-protecting drugs, dietary improvements, and exercise to boost bone health. Regular monitoring through imaging and tests helps detect early signs of bone metastasis, allowing for timely treatment and improved patient outcomes.
